Korro Bio Inc (KRRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -38,541 | -19,625 | -117,260 | -67,218 | -49,157 |
| Depreciation Amortization | 748 | 382 | 3,791 | 3,164 | 2,032 |
| Accounts receivable | 969 | 969 | 727 | 876 | 607 |
| Accounts payable and accrued liabilities | 1,952 | -153 | -2,311 | -1,674 | 1,194 |
| Other Working Capital | -1,192 | 196 | -4,426 | -2,974 | -721 |
| Other Operating Activity | 2,997 | 2,157 | 40,918 | 6,967 | 2,365 |
| Operating Cash Flow | $-33,067 | $-16,074 | $-78,561 | $-60,859 | $-43,680 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 25,000 | 13,000 | 70,700 | 55,700 | 32,901 |
| PPE Investments | -58 | -21 | -518 | -434 | -259 |
| Purchase Of Investment | -75,083 | -45,219 | -26,189 | -26,189 | -11,161 |
| Investing Cash Flow | $-50,141 | $-32,240 | $43,993 | $29,077 | $21,481 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 85,295 | 88,212 | 685 | 305 | 177 |
| Financing Cash Flow | $85,295 | $88,212 | $685 | $305 | $177 |
| Exchange Rate Effect | -3 | -25 | 64 | -11 | -9 |
| Beginning Cash Position | 25,230 | 25,230 | 59,049 | 59,049 | 59,049 |
| End Cash Position | 27,314 | 65,103 | 25,230 | 27,561 | 37,018 |
| Net Cash Flow | $2,084 | $39,873 | $-33,819 | $-31,488 | $-22,031 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,067 | -16,074 | -78,561 | -60,859 | -43,680 |
| Capital Expenditure | -58 | -21 | -518 | -434 | -259 |
| Free Cash Flow | -33,125 | -16,095 | -79,079 | -61,293 | -43,939 |